NCT00513552View on ClinicalTrials.gov

Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Crohn's Disease
Interventions
DRUG

Rifabutin, Clarithromycin, and Clofazimine

Rifabutin 150 mg by mouth twice daily, Clarithromycin 250 mg by mouth twice a day, and Clofazimine 100 mg by mouth each morning

Sponsors
All Listed Sponsors
lead

Medstar Health Research Institute

OTHER